Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The primary market driver for healthcare predictive analytics is the surfacing of personalized and evidence-based medicine. It helps in managing inherited disorders through prediction of molecular pathology, accurate diagnosis and assessing phenotypic correlations. This information results in efficient personal healthcare. Another factor increasing the need for predictive analysis in the healthcare industry is the efficiency enhancement of the processes currently followed. This can be done by reducing unnecessary cost, thereby, curtailing overall costs of current systems. As mentioned earlier, another driver for the market is the exponential expansion of data via various tools which will require appropriate usage of predictive analytics. Advancements in this field will also give rise to better systems which will reduce the penalties due to the failure of controlling adverse conditions. However, the area is a new application of technology, availability of labor with required skill set is lacking, which might hinder the growth of the market. Furthermore, the high initial costs associated with usage of the technologies required for implementing predictive analytics is another major inhibitor for the market. Additionally, the integrity of data and safety associated with it may also negatively impact the market as it might make healthcare industries refrain from sharing data with analytics firm.
Market Segmentation
The healthcare predictive analytics market can be segmented via application, component, mode of deployment, geography and end user. By application, the market is segmented into Clinical Data Analytics, Financial Data Analytics, Administrative Data Analytics and Research Data Analytics. Segmentation by component gives software, hardware, and services. By mode of deployment, the market is categorized as On-Premise, Web-Based and Cloud-Based. Regarding geography, North America, Europe, Asia-Pacific and, Middle East and Africa gives the segmentation of the market. The market is classified as hospitals, physicians, clinics, government organizations and research institutions, via end-user segmentation.
Geographical Analysis
Currently, North America (majorly U.S.) is the leader because of implementation of EHR and GPS enabled systems. Europe has second largest share while Asia-Pacific market is expected to increase at a relatively higher rate. In MEA, Saudi Arabia and South Africa are key markets.
Key Players
IBM, Cerner, Oracle, McKesson Corporation, Optum Inc., Verisk Analytics, TruvenHealthAnalytics are some of the major market players.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...